Reliferon 3MIU Injection 0.5 ml

Reliferon 3MIU Injection 0.5 ml is an anti-cancer medicine used in the treatment of hairy cell leukaemia, follicular leukaemia, malignant leukaemia, AIDS-Related Kaposi’s Sarcoma, Hodgkin’s Lymphoma in combination with anthracycline-containing chemotherapy medicine, chronic hepatitis B and C. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.

Reliferon 3MIU Injection 0.5 ml contains Interferon alpha 2b as an active ingredient, which belongs to the class of immunomodulators. It works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body. 

Reliferon 3MIU Injection 0.5 ml may cause certain side effects such as flu-like symptoms, diarrhoea, fatigue, nausea, headache, dizziness, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, consult your doctor. Reliferon 3MIU Injection 0.5 ml will be administered by a trained doctor. Hence, do not self-administer.

Avoid taking it and inform your doctor if you are allergic to Reliferon 3MIU Injection 0.5 ml or its components. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects. $ is not recommended for use in pregnancy as it is known to cause fetal harm. Breastfeeding should be avoided when on treatment with Reliferon 3MIU Injection 0.5 ml.

Reliferon 3MIU Injection 0.5 ml contains Interferon alpha 2B, which is used for treating patients with different types of cancer. This medicine works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.

• Nausea
• Vomiting
• Diarrhoea
• Headache
• Fatigue
• Injection site reactions
• Pain at the site of injection
• Fever
• Back pain

Reliferon 3MIU Injection 0.5 ml should be avoided if you are allergic to it or any other components of this medicine. Before taking Reliferon 3MIU Injection 0.5 ml, inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects.. Reliferon 3MIU Injection 0.5 ml may cause fetal harm. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Reliferon 3MIU Injection 0.5 ml is not recommended for use in children as the safety and efficacy are not established.

• ETANERCEPT
• GOLIMUMAB
• ABCIXIMAB
• APIXABAN
• DICUMAROL

• Regular, complete blood count monitoring is advised during the treatment.
• Liver function tests (LFT) and kidney function tests (RFT) should be performed before starting the treatment and every 4 to 6 weeks during the treatment.
• Regular ECG, blood pressure, and electrolytes should be monitored while taking the medicine.

• Meditation and yoga have been proven very effective in helping cancer patients maintain a healthy attitude and body.
• Eat more lean meats, healthy fats, fruits, vegetables, and whole-grain foods to give you more energy. 
• Stay hydrated by drinking plenty of water, as dehydration is often seen in cancers.
• Taking a stroll in the garden or spending 30 minutes of your time doing some light physical activity can be very useful. However, do not over-exert yourself if you feel too tired. 
• Avoid smoking and alcohol consumption.